News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • IG Metall called a 24-hour strike Monday involving 23,000 workers at 19 northern German firms.
  • Affected companies include Mercedes-Benz, Meyer Werft and Siemens Gamesa, hitting automakers, shipyards and wind supply chains.
  • Union demands a 5% wage increase or binding investment and job commitments from firms seeking exceptions.
  • Employers proposed delaying permanent pay gains 20 months and a 1.3% raise effective July 2028.
  • The strike raises near-term disruption risk for German industrial output and supply chains.
  • COP31 negotiators released a revised text narrowing language on fossil fuels as delegations race toward approval.

Latest Articles

PureCycle & Mitsui Announce Strategic Partnership with RM TOHCELLO to Bring Recycled Polypropylene to Flexible Packaging in Japan

PureCycle & Mitsui Announce Strategic Partnership with RM TOHCELLO to Bring Recycled Polypropylene to Flexible Packaging in Japan

PureCycle Technologies, Inc. has announced a strategic partnership with RM TOHCELLO and Mitsui to develop and commercialize recycled polypropylene resin for use in high-quality biaxially oriented polypropylene (BOPP) films. This collaboration addresses a key challenge in sustainable packaging by enabling recycled content in flexible films, a growin…

Allogene Therapeutics Announces Journal of Clinical Oncology Publication of Phase 1 Results of ALLO-316 Highlighting First Durable Remissions Following Allogeneic CAR T for Treatment of Metastatic Solid Tumors

Allogene Therapeutics Announces Journal of Clinical Oncology Publication of Phase 1 Results of ALLO-316 Highlighting First Durable Remissions Following Allogeneic CAR T for Treatment of Metastatic Solid Tumors

Allogene Therapeutics announced the publication of Phase 1 results for ALLO-316, an allogeneic CAR T therapy targeting CD70 in metastatic renal cell carcinoma (RCC). The TRAVERSE study demonstrated a confirmed response rate of 31% in patients with high CD70 expression, with durable remissions persisting 8 to over 18 months and manageable safety pro…

JPMorgan Nears Historic $1 Trillion Valuation After Record Quarter

JPMorgan Nears Historic $1 Trillion Valuation After Record Quarter

JPMorgan Chase, under Jamie Dimon’s long-running leadership, has pushed its market value close to $1 trillion following a record profit and a robust quarter for trading and investment banking. The bank’s size and diversified operations have amplified gains, yet reaching the milestone raises investor expectations and exposes the firm to potential vo…

U.N. Warns Profits from Sudan’s Gum Arabic Trade Are Fueling Ongoing Conflict

U.N. Warns Profits from Sudan’s Gum Arabic Trade Are Fueling Ongoing Conflict

The U.N. human rights office says revenues from Sudan’s gum arabic sector are helping to sustain the country’s four-year civil war. Producing roughly 80% of the global supply, Sudan’s gum arabic is a common ingredient in soft drinks, pharmaceuticals and cosmetics. The U.N. report documents seizures, smuggling through neighbouring transit states and…

Electra Secures Safran Production Pact for TG600 Turbogenerators

Electra Secures Safran Production Pact for TG600 Turbogenerators

Electra has inked a production agreement with Safran Helicopter Engines to supply TG600 turbogenerators, beginning with an initial 250-unit order. The arrangement is designed to scale output in line with demand for Electra’s nine-passenger EL9 Ultra Short aircraft as the startup advances development and certification work toward an expected first f…

Progressive Reports June 2026 Results

Progressive Reports June 2026 Results

The Progressive Corporation announced its financial results for June 2026, showing increases in net premiums written and earned, alongside a small rise in net income for the quarter. Despite a 31% decline in monthly net income compared to prior year, the quarterly net income improved 4%. The company maintained growth in policies in force across per…

Eos Energy Enterprises Announces Preliminary Second Quarter 2026 Financial Results, Expects Record Quarterly Revenue and Backlog, and Sets Second Quarter 2026 Conference Call Date

Eos Energy Enterprises Announces Preliminary Second Quarter 2026 Financial Results, Expects Record Quarterly Revenue and Backlog, and Sets Second Quarter 2026 Conference Call Date

Eos Energy Enterprises announced preliminary Q2 2026 financial results showing record quarterly revenue between $68 million and $69 million, driven by a threefold increase in shipments and a backlog growth to approximately $807 million. The company began commercial production on its second battery line, expanding capacity and setting the stage for …

Biogen Appoints Michael J. Parini as Chief Legal Officer

Biogen Appoints Michael J. Parini as Chief Legal Officer

Biogen Inc. has appointed Michael J. Parini as its new Chief Legal Officer, effective August 3, 2026. Parini brings over 20 years of legal and biopharmaceutical industry leadership experience, including roles at Spur Therapeutics, Vertex Pharmaceuticals, and Pfizer. He will oversee Biogen's global legal and compliance functions, contributing to the…

Kepler Cheuvreux Moves Sandvik to Hold as Rally Narrows Valuation Gap

Kepler Cheuvreux Moves Sandvik to Hold as Rally Narrows Valuation Gap

Kepler Cheuvreux cut its recommendation on Sandvik to hold from buy after the mining and machining group’s stock climbed nearly 70% over the past year, narrowing its discount to Nordic quality peers. The broker raised its price target to 400 Swedish crowns and updated sales and earnings forecasts while flagging caution about whether recent machinin…

Conagra Shares Fall After Downbeat Fiscal 2027 Guidance and Dividend Cut

Conagra Shares Fall After Downbeat Fiscal 2027 Guidance and Dividend Cut

Conagra Brands shares tumbled in pre-market trading after the packaged foods company issued fiscal 2027 guidance that fell short of analyst expectations and revealed a 50% cut to its quarterly dividend. Management cited elevated commodity costs, including rising beef prices and tariff-related steel pressures, as headwinds to near-term results. The …

BofA Reports Surge in Financials Inflows as Q2 Earnings Season Begins

BofA Reports Surge in Financials Inflows as Q2 Earnings Season Begins

Bank of America clients increased allocations to U.S. equities for a second consecutive week, driven by heavy institutional buying. Single-stock purchases reached $5.1 billion - the third-largest weekly total since 2008 - while equity ETFs attracted $1.8 billion. Financials posted the largest sector-level single-stock inflows in more than a decade …

VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Growth of 500%+ in FY2027

VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Growth of 500%+ in FY2027

VivoSim Labs, Inc. reported receiving a $5 million milestone payment from Eli Lilly linked to the advancement of a drug acquired from VivoSim's inflammatory bowel disease program. The company projects over 500% revenue growth in fiscal year 2027 driven by strong customer adoption of its innovative NAM-based 3D human cellular models for preclinical …

Kratos Opens New 167,000-Square-Foot Manufacturing Facility in Pennsylvania, Expanding Existing Footprint in the State

Kratos Opens New 167,000-Square-Foot Manufacturing Facility in Pennsylvania, Expanding Existing Footprint in the State

Kratos Defense & Security Solutions has opened a new 167,000-square-foot manufacturing facility in York, Pennsylvania, expanding its existing operations to support critical national security programs including hypersonic systems, missile defense, radar, and counter-unmanned aircraft systems. The company plans to invest over $7 million in new manufa…

aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026

aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026

aTyr Pharma announced subgroup analysis from their Phase 3 EFZO-FIT study showing clinically meaningful improvements in lung function and multiple patient-reported outcomes in pulmonary sarcoidosis patients with restrictive lung disease treated with 5.0 mg/kg efzofitimod. The company submitted a protocol to the FDA for a targeted Phase 3 study focu…

Greenland Mines Reports 36–44% PdEq Grade Uplift and +31% Increase in Indicated PdEq Ounces at its Skaergaard Gold, Palladium, Platinum Project in First S-K 1300 Technical Report Summary

Greenland Mines Reports 36–44% PdEq Grade Uplift and +31% Increase in Indicated PdEq Ounces at its Skaergaard Gold, Palladium, Platinum Project in First S-K 1300 Technical Report Summary

Greenland Mines Ltd announced a substantial upgrade to its Skaergaard precious and critical metals project mineral resource estimate under the SEC's new S-K 1300 reporting standards. The updated 2026 Mineral Resource Estimate shows a 31% increase in indicated PdEq ounces and a 36% uplift in grade compared to the 2022 baseline, supported by improved…

MediciNova Announces Patient Enrollment Milestone Achieved in SEANOBI Study Expanded-Access-Program Evaluating MN‑166 (ibudilast) in ALS patients

MediciNova Announces Patient Enrollment Milestone Achieved in SEANOBI Study Expanded-Access-Program Evaluating MN‑166 (ibudilast) in ALS patients

MediciNova, Inc. announced reaching the target enrollment of 200 patients in the NIH-funded SEANOBI-ALS study assessing their investigational drug MN-166 (ibudilast) for amyotrophic lateral sclerosis (ALS). The Expanded Access Program provides treatment to patients ineligible for other trials, marking a significant milestone in patient engagement. …